ARG1 and Alzheimer disease: Reduced levels of arginase 1, as we identified in the mSOD1 mice, have been shown to be linked to the existence of neuropathological mechanisms, neuroinflammation, and behavioural deficits in an AD mouse model [51] and to dysfunctional microglia in the SC of mSOD1 rats at disease end-stage [104].